相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
Frances Humby et al.
LANCET (2021)
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus
Roberto Giacomelli et al.
AUTOIMMUNITY REVIEWS (2021)
Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study
Masaru Kato et al.
MODERN RHEUMATOLOGY (2020)
Efficacy, Safety, and Sample Quality of Ultrasound-Guided Synovial Needle Biopsy in Clinical Practice and Research: A Prospective Observational Study
Vasco C. Romao et al.
ARTHRITIS CARE & RESEARCH (2020)
Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis
Nisha Nair et al.
RHEUMATOLOGY (2020)
B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure
F. Rivellese et al.
ARTHRITIS & RHEUMATOLOGY (2020)
A Pauci-Immune Synovial Pathotype Predicts Inadequate Response to TNFα-Blockade in Rheumatoid Arthritis Patients
Alessandra Nerviani et al.
FRONTIERS IN IMMUNOLOGY (2020)
Notch signalling drives synovial fibroblast identity and arthritis pathology
Kevin Wei et al.
NATURE (2020)
Using pharmacogenetics to predict methotrexate response in rheumatoid arthritis patients
Bartosz Szostak et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response
Dmitry S. Mikhaylenko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transforming clinical trials in rheumatology: towards patient-centric precision medicine
Costantino Pitzalis et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis
Antonio Julia et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
Frances Humby et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Proteomic analysis of synovial fluid: current and potential uses to improve clinical outcomes
Mandy Jayne Peffers et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial
Karen Hambardzumyan et al.
JOURNAL OF RHEUMATOLOGY (2019)
Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39
Athina Spiliopoulou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Distinct fibroblast subsets drive inflammation and damage in arthritis
Adam P. Croft et al.
NATURE (2019)
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
Fan Zhang et al.
NATURE IMMUNOLOGY (2019)
A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis
Adria Aterido et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Potential Role of Genomic Medicine in the Therapeutic Management of Rheumatoid Arthritis
Marialbert Acosta-Herrera et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
Myles J. Lewis et al.
CELL REPORTS (2019)
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
Gloria Lliso-Ribera et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis
Xin Wu et al.
FRONTIERS OF MEDICINE (2019)
Synovial Tissue Sampling in Rheumatological Practice-Past Developments and Future Perspectives
Frances C. Humby
FRONTIERS IN MEDICINE (2019)
Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
Ben Mulhearn et al.
JOURNAL OF PERSONALIZED MEDICINE (2019)
Synovial Tissue Biopsy Research
Douglas J. Veale
FRONTIERS IN MEDICINE (2019)
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-alpha Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study
Leslie R. Harrold et al.
JOURNAL OF RHEUMATOLOGY (2018)
Genome-wide association study of response to methotrexate in early rheumatoid arthritis patients
John C. Taylor et al.
PHARMACOGENOMICS JOURNAL (2018)
Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis
Fumitaka Mizoguchi et al.
NATURE COMMUNICATIONS (2018)
Rheumatoid arthritis
Josef S. Smolen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis
Jonathan Massey et al.
PHARMACOGENOMICS JOURNAL (2018)
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe
Soren Andreas Just et al.
RMD OPEN (2018)
Predictors of remission with etanercept-methotrexate induction therapy and loss of remission with etanercept maintenance, reduction, or withdrawal in moderately active rheumatoid arthritis: results of the PRESERVE trial
Josef S. Smolen et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the pan-European registry collaboration for abatacept (PANABA)
Florenzo Iannone et al.
CLINICAL RHEUMATOLOGY (2017)
Arthroscopic guided synovial biopsy in rheumatology: current perspectives
Mihir D. Wechalekar et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Yang Liu et al.
ARTHRITIS CARE & RESEARCH (2017)
The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study
Xavier Mariette et al.
JOINT BONE SPINE (2017)
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis
Deepak A. Rao et al.
NATURE (2017)
Synovial tissue research: a state-of-the-art review
Carl Orr et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients Relationship to Treatment Response and Radiologic Prognosis
Carl Orr et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial
Adrian Levitsky et al.
RMD OPEN (2017)
Body mass index and clinical response to intravenous or subcutaneous abatacept in patients with rheumatoid arthritis
Maria-Antonietta D'Agostino et al.
CLINICAL RHEUMATOLOGY (2017)
Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis
Hilde Haugedal Nordal et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Increased pretreatment serum IFN-/ ratio predicts non-response to tumour necrosis factor inhibition in rheumatoid arthritis
Theresa Wampler Muskardin et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study
A. Gardette et al.
CLINICAL RHEUMATOLOGY (2016)
Relationship Between Baseline and Early Changes in C-Reactive Protein and Interleukin-6 Levels and Clinical Response to Tocilizumab in Rheumatoid Arthritis
Jianmei Wang et al.
ARTHRITIS CARE & RESEARCH (2016)
Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
J. E. Gottenberg et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
Anne C. Bay-Jensen et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Body Mass Index and response to rituximab in rheumatoid arthritis
Sebastien Ottaviani et al.
JOINT BONE SPINE (2015)
Association of Body Mass Index Categories with Disease Activity and Radiographic Joint Damage in Rheumatoid Arthritis: A Systematic Review and Metaanalysis
Celine Vidal et al.
JOURNAL OF RHEUMATOLOGY (2015)
Response to Tocilizumab in Rheumatoid Arthritis Is Not Influenced by the Body Mass Index of the Patient
Yves-Marie Pers et al.
JOURNAL OF RHEUMATOLOGY (2015)
Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis
R. A. M. Quax et al.
RHEUMATOLOGY INTERNATIONAL (2015)
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
J. S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy
Helen L. Wright et al.
RHEUMATOLOGY (2015)
Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register
Helena Forsblad-d'Elia et al.
RHEUMATOLOGY (2015)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
Glynn Dennis et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients
Lavanya Balakrishnan et al.
CLINICAL PROTEOMICS (2014)
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
John D. Isaacs et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis
Masa Umicevic Mirkov et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Obesity and reduction of the response rate to anti-tumor necrosis factor a in rheumatoid arthritis: An approach to a personalized medicine
Elisa Gremese et al.
ARTHRITIS CARE & RESEARCH (2013)
Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF
Jesus Mateos et al.
JOURNAL OF PROTEOMICS (2012)
Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy
Helen L. Wright et al.
RHEUMATOLOGY (2012)
The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
Hennie G. Raterman et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
Brandon W. Higgs et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Body Mass Index and Clinical Response to Infliximab in Rheumatoid Arthritis
Ruth Klaasen et al.
ARTHRITIS AND RHEUMATISM (2011)
Obesity in rheumatoid arthritis
Antonios Stavropoulos-Kalinoglou et al.
RHEUMATOLOGY (2011)
Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases
Athan Baillet et al.
RHEUMATOLOGY (2010)
Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis
C. Potter et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Utility of synovial biopsy
Stefan Vordenbaeumen et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
Frances Humby et al.
PLOS MEDICINE (2009)
Standardisation of synovial tissue infiltrate analysis: how far have we come? how much further do we need to go?
MD Smith et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
分享论文
